Clinical value of determination of markers of a thrombophylia at patients with the complicated pregnancy in the anamnesis

Margarita Darchoevna Andreeva

doi:10.17816/JOWD64213-17

Journal of obstetrics and women's diseases ›› 2015, Vol. 64 ›› Issue (2) : 13 -17. DOI: 10.17816/JOWD64213-17

Articles

research-article

Clinical value of determination of markers of a thrombophylia at patients with the complicated pregnancy in the anamnesis

Margarita Darchoevna Andreeva

Author information +

History +

PDF

Abstract

The results of the survey of 214 patients with the complicated pregnancy (a preeclampsia, a premature detachment of placenta, antenatal fetal death, miscarriage) in the anamnesis are presented in the article. We determined the level of molecular markers of a thrombophilia (TAT, D-dimer) and aggregation activity of platelets and carried out antithrombotic therapy to these women. It is shown that 47,7 % of such nonpregnant women and pregnant early terms have the high level of D-dimer, TAT - 46,7 %, aggregation activity of platelets - 52,6 %. Determination of the increased levels of molecular markers of a thrombophilia is the indication to application the antithrombotic therapy and allow to control efficiency of this therapy.

Keywords

D-dimer / TAT / thrombophilia / markers of thrombophilia / preeclampsia / premature detachment of placenta / antenatal fetal death / miscarriage

Cite this article

Download citation ▾

Margarita Darchoevna Andreeva. Clinical value of determination of markers of a thrombophylia at patients with the complicated pregnancy in the anamnesis. Journal of obstetrics and women's diseases, 2015, 64(2): 13-17 DOI:10.17816/JOWD64213-17

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	Самбурова Н. В. Клиническое значение контроля маркеров активации свертывания крови при проведении противотромботической терапии у беременных, рожениц и родильниц с тромбофилией: дис… канд. мед. наук. М. 2008; 132 с.

[2]	Тромбогеморрагические осложнения в акушерско-гинекологической практике: Руководство для врачей. Под ред. А. Д. Макацария. М. 2011; 1056 с.

[3]	Kovac M., Mitic G. et al. Thrombophilia in women with pregnancy-associated complications: fetal loss and pregnancy-related venous thromboembolism. Gynecol. Obstet. Invest. 2010; 69 (4): 233-8.

[4]	Lykke J. A., Bare L. A., Olsen J. et al. Thrombophilias and adverse pregnancy outcomes: results from the Danish National Birth Cohort. J. Thromb. Haemost. 2012; 10 (7): 1320-5.

[5]	Pabinger I. Thrombophilia and its impact on pregnancy. Thromb Res. 2009; 123 (3): 16-21.

[6]	Rodger M. A. An update on thrombophilia and placenta mediated pregnancy complications: What should we tell our patients? Thromb. Res. 2013; 131 (1): 25-7.